Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 19 June 2009

European Journal of Endocrinology 2009;161:419.

DOI: 10.1530/EJE-09-0308
Copyright © 2009 by European Society of Endocrinology
This Article
Right arrow Accepted manuscript (PDF)
Right arrow All Versions of this Article:
EJE-09-0308v1
161/3/419    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mericq, V.
Right arrow Articles by Iniguez, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mericq, V.
Right arrow Articles by Iniguez, G.

Differences in expression and activity of 11 beta-hydroxysteroid dehydrogenase (11-βHSD) type 1 and 2 in human placentas of term pregnancies according to birth weight and gender

Veronica Mericq, Pablo Medina, Elena Kakarieka, Lorena Marquez, Maria Cecilia Johnson and German Iniguez

V Mericq, IDIMI, School of Medicine, University of Chile, Santiago, Chile
P Medina, IDIMI, School of Medicine, University of Chile, Santiago, Chile
E Kakarieka, Hospital Clinico San Borja Arriaran, Santiago, Chile
L Marquez, Chile, Chile
M Johnson, Santiago, Chile
G Iniguez, IDIMI, School of Medicine, University of Chile, Santiago, 7591289, Chile

Correspondence: German Iniguez, Email: giniguez{at}med.uchile.cl

Fetal exposure to maternal glucocorticoids may determine fetal growth and the programming of later disorders. Availability of the glucocorticoids in the placenta is regulated by the 11β-HSDs enzymes. Up-to-date there are discrepancies with regard to cortisol (F) cord blood levels in fetuses with IUGR in different species. Objective: To study the expression and activity of 11β-HSDs in placentas from full term SGA,AGA and LGA newborns and cortisol cord blood concentration. Methods: Twenty five placentas from AGA, 24 SGA and 25 LGA. Results: SGA newborns had significantly lower and LGA newborns significantly higher birth weight, birth length, head circumference, and placental weight than AGA counterparts. We observed a direct correlation between placental weight and birth weight, birth length and head circumference, and higher cord F levels in SGA newborns. The 11β-HSD-1 expression was similar among the SGA,AGA and LGA placentas. However, within the placentas of SGA newborns the 11β-HSD-1 mRNA levels were significantly reduced in the chorionic plate compared with basal plate. An inverse correlation between cord F levels and activity of 11β-HSD1 in the chorionic plate of the SGA placentas was detected. The 11β-HSD-2 activity was 7-8 fold higher compared to 11β-HSD-1 in the placentas, and there was a lower 11β-HSD-2 activity in females SGA placentas compared with the male SGA placentas. Conclusion: We observed a lower expression and activity of 11β-HSD1 in the chorionic plate of the SGA placentas suggesting a possible compensatory mechanism to diminish the higher cortisol fetal concentrations observed in fetuses with intrauterine growth restriction.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 European Society of Endocrinology.